Prevalence of Covid-19 Symptoms Among Inflammatory Bowel Disease Patients Treated with Biological Agents.

Conley, Thomas E; Probert, Chris; Subramanian, Sreedhar

Conley, Thomas E; Probert, Chris; Subramanian, Sreedhar.

Affiliation

Conley TE; Department of Gastroenterology, Liverpool University Foundation Hospitals NHS Trust, Liverpool, UK.
Probert C; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool, UK.
Subramanian S; Department of Gastroenterology, Liverpool University Foundation Hospitals NHS Trust, Liverpool, UK.

J Crohns Colitis ; 14(12): 1794-1795, 2020 Dec 02.

Article de En | MEDLINE | ID: mdl-32918090

Sujet(s)
Mots clés

Covid-19; Inflammatory bowel disease; biologics

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies inflammatoires intestinales / Facteurs biologiques / COVID-19 / Agents immunomodulateurs Type d'étude: Diagnostic_studies / Etiology_studies / Prevalence_studies Aspects: Patient_preference Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: J Crohns Colitis Sujet du journal: GASTROENTEROLOGIA Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google